<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03873506</url>
  </required_header>
  <id_info>
    <org_study_id>yunqiu xia</org_study_id>
    <nct_id>NCT03873506</nct_id>
  </id_info>
  <brief_title>Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia</brief_title>
  <official_title>Follow-Up Study of Safety and Efficacy of Mesenchymal Stem Cells in Preterm Infants With Moderate or Severe Bronchopulmonary Dysplasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Chongqing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a follow-up study to investigate the long-term safety and efficacy of human umbilical
      cord -derived mesenchymal stem cells (hUC-MSCs), for the treatment of BPD in premature
      infants. Subjects who participated in and completed the initial stage of the PhaseⅠtrial
      (NCT03558334 ) will be followed-up until 48 months after the hUC-MSCs transplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects who completed the initial stage of the PhaseⅠclinical trial will be followed-up at 5
      additional visits: 1, 3, 6, 12 and 24 months after the hUC-MSCs transplantation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>within two years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of the hospital stay due to respiratory infection</measure>
    <time_frame>within two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Survival</measure>
    <time_frame>within two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Tumorigenicity</measure>
    <time_frame>within two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth measured by Z-score</measure>
    <time_frame>within two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of neurological developmental delay</measure>
    <time_frame>within two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of blindness and deafness</measure>
    <time_frame>within two years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <arm_group>
    <arm_group_label>Mesenchymal Stem Cell</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A single intravenous transplantation of Mesenchymal Stem Cell (Dose A - 1 million cells per kg, Dose B - 5 million cells per kg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>transplantation of hUC-MSCs</intervention_name>
    <description>Human umbilical cord-derived mesenchymal stem cells had given to preterm infants through intravenous infusion.</description>
    <arm_group_label>Mesenchymal Stem Cell</arm_group_label>
    <other_name>intravenous infusion of hUC-MSCs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject who completed the safety and efficacy evaluations in hUC-MSCs PhaseⅠ clinical
             trial

          2. Subject with a written consent form signed by a legal representative or a parent

        Exclusion Criteria:

          1. Subject whose parent or legal representative does not agree to participate in the
             study

          2. subject who is considered inappropriate to participate the study by the investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhou Fu</last_name>
    <role>Study Chair</role>
    <affiliation>Children's Hospital of Chongqing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yunqiu Xia</last_name>
    <phone>13637719980</phone>
    <email>sunny_199001@foxmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lin Zou</last_name>
    <phone>18623121280</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunqiu Xia</last_name>
      <phone>13637719980</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI, Park WS. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 2014 May;164(5):966-972.e6. doi: 10.1016/j.jpeds.2013.12.011. Epub 2014 Feb 6.</citation>
    <PMID>24508444</PMID>
  </reference>
  <reference>
    <citation>Ahn SY, Chang YS, Kim JH, Sung SI, Park WS. Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia. J Pediatr. 2017 Jun;185:49-54.e2. doi: 10.1016/j.jpeds.2017.02.061. Epub 2017 Mar 21.</citation>
    <PMID>28341525</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>March 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2019</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Xia Yunqiu</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>Bronchopulmonary Dysplasia</keyword>
  <keyword>human umbilical cord -derived mesenchymal stem cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
    <mesh_term>Hyperplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

